 | Up a level |
Schindewolf, Marc; Banik, Norbert; Lindhoff-Last, Edelgard (2018). Reply: Fondaparinux and Direct Oral Anticoagulants: Promising Anticoagulant for Management of Heparin-Induced Thrombocytopenia. Journal of the American College of Cardiology, 71(15), pp. 1710-1712. Elsevier 10.1016/j.jacc.2018.02.026
Schindewolf, Marc; Steindl, Julia; Beyer-Westendorf, Jan; Schellong, Sebastian; Dohmen, Pascal Maria; Brachmann, Johannes; Madlener, Katharina; Pötzsch, Bernd; Klamroth, Robert; Hankowitz, Johannes; Banik, Norbert; Eberle, Sonja; Müller, Markus Michael; Kropff, Stefan; Lindhoff-Last, Edelgard (2017). Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia. Journal of the American College of Cardiology, 70(21), pp. 2636-2648. Elsevier 10.1016/j.jacc.2017.09.1099
Schindewolf, Marc; Recke, Andreas; Zillikens, Detlef; Lindhoff-Last, Edelgard; Ludwig, Ralf J (2017). Nadroparin carries a potentially high risk of inducing cutaneous delayed-type hypersensitivity responses. Contact dermatitis, 77(1), pp. 35-41. Wiley-Blackwell 10.1111/cod.12764
Reyher, Christian; Würfel, Claire; Lindhoff-Last, Edelgard; Meybohm, Patrick; Zacharowski, Kai; Moritz, Anton; Schindewolf, Marc; Weber, Christian Friedrich (2016). Antifactor Xa Activity for the Management of Anticoagulation during Cardiac Surgery. Thoracic and cardiovascular surgeon, 64(06), pp. 494-500. Thieme 10.1055/s-0035-1570035
Weingarz, Lea; Schindewolf, Marc; Schwonberg, Jan; Hecking, Carola; Wolf, Zsuzsanna; Erbe, Matthias; Lindhoff-Last, Edelgard; Linnemann, Birgit (2015). Thrombophilia and risk of VTE recurrence according to the age at the time of first VTE manifestation. Vasa - European journal of vascular medicine, 44(4), pp. 313-323. Huber 10.1024/0301-1526/a000447
Schindewolf, Marc; Scheuermann, Julia; Kroll, Hartmut; Marzi, Ingo; Kaufmann, Roland; Boehncke, Wolf-Henning; Ludwig, Ralf J; Lindhoff-Last, Edelgard (2012). Application, tolerance and safety of fondaparinux therapy in a German hospital: a prospective single-centre experience. Thrombosis research, 129(1), pp. 17-21. Elsevier 10.1016/j.thromres.2011.06.008
Walter, Dirk H; Krankenberg, Hans; Balzer, Jörn O; Kalka, Christoph; Baumgartner, Iris; Schlüter, Michael; Tonn, Torsten; Seeger, Florian; Dimmeler, Stefanie; Lindhoff-Last, Edelgard; Zeiher, Andreas M (2011). Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circulation: Cardiovascular interventions, 4(1), pp. 26-37. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1161/CIRCINTERVENTIONS.110.958348
